Carisma Therapeutics (US:CARM) Prnewswire·2025-02-05 12:30Group 1 - Carisma Therapeutics Inc. is a leader in macrophage-focused therapeutics and will participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference on February 11, 2025 [1] - The event will feature Steven Kelly, the President and CEO of Carisma, and will take place at 4:40 pm ET [1] - An audio webcast of the conference will be available on the Company's Investor Events section and archived for a limited time [2] Group 2 - Carisma Therapeutics is pioneering macrophage engineering to develop therapies for fibrosis, cancer, and other diseases [3] - The Company is committed to patient-centric innovation and aims to deliver scalable, next-generation solutions that transform treatment paradigms [3] - Carisma is headquartered in Philadelphia, PA, and more information can be found on their website [3]